AXSM vs. DY
AXSM (Axsome Therapeutics, Inc.) and DY (Dycom Industries, Inc.) are both stocks. AXSM operates in Biotechnology (Healthcare), while DY operates in Engineering & Construction (Industrials). Over the past 10 years, AXSM returned 44.70%/yr vs 18.68%/yr for DY. At a 0.21 correlation, their price movements are largely independent.
Performance
AXSM vs. DY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with AXSM having a 39.71% return and DY slightly lower at 38.80%. Over the past 10 years, AXSM has outperformed DY with an annualized return of 44.70%, while DY has yielded a comparatively lower 18.68% annualized return.
AXSM
- 1D
- 0.55%
- 1M
- 12.05%
- YTD
- 39.71%
- 6M
- 72.21%
- 1Y
- 145.12%
- 3Y*
- 50.48%
- 5Y*
- 30.90%
- 10Y*
- 44.70%
DY
- 1D
- 0.95%
- 1M
- 7.23%
- YTD
- 38.80%
- 6M
- 35.64%
- 1Y
- 101.16%
- 3Y*
- 64.20%
- 5Y*
- 42.09%
- 10Y*
- 18.68%
AXSM vs. DY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 39.71% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
DY Dycom Industries, Inc. | 38.80% | 94.13% | 51.24% | 22.96% | -0.17% | 24.15% | 60.17% | -12.75% | -51.50% | 38.78% |
Correlation
The correlation between AXSM and DY is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2015 | 0.21 |
Fundamentals
AXSM:
$13.06B
DY:
$14.25B
AXSM:
-$3.74
DY:
$10.52
AXSM:
18.13
DY:
2.22
AXSM:
239.33
DY:
7.52
AXSM:
$708.24M
DY:
$6.25B
AXSM:
$655.82M
DY:
$1.23B
AXSM:
-$172.72M
DY:
$1.07B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXSM vs. DY — Risk / Return Rank
AXSM
DY
AXSM vs. DY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Dycom Industries, Inc. (DY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AXSM | DY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.18 | ||
| Sortino ratioReturn per unit of downside risk | +1.54 | ||
| Omega ratioGain probability vs. loss probability | 1.57 | 1.39 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 7.62 | 4.08 | +3.54 |
| Martin ratioReturn relative to average drawdown | 22.44 | 13.38 | +9.05 |
Loading charts...
Drawdowns
AXSM vs. DY - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum DY drawdown of -93.54%. Use the drawdown chart below to compare losses from any high point for AXSM and DY.
Loading charts...
Drawdown Indicators
| AXSM | DY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.65% | -93.54% | +6.89% |
Max Drawdown (1Y)Largest decline over 1 year | -18.50% | -24.43% | +5.93% |
Max Drawdown (3Y)Largest decline over 3 years | -36.45% | -32.58% | -3.87% |
Max Drawdown (5Y)Largest decline over 5 years | -72.91% | -33.70% | -39.21% |
Max Drawdown (10Y)Largest decline over 10 years | -81.26% | -89.01% | +7.75% |
Current DrawdownCurrent decline from peak | 0.00% | -12.37% | +12.37% |
Average DrawdownAverage peak-to-trough decline | -39.47% | -45.66% | +6.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.31% | 7.43% | -1.12% |
Volatility
AXSM vs. DY - Volatility Comparison
The current volatility for Axsome Therapeutics, Inc. (AXSM) is 9.24%, while Dycom Industries, Inc. (DY) has a volatility of 26.09%. This indicates that AXSM experiences smaller price fluctuations and is considered to be less risky than DY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AXSM | DY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.24% | 26.09% | -16.85% |
Volatility (6M)Calculated over the trailing 6-month period | 33.14% | 38.40% | -5.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.89% | 45.60% | -3.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.25% | 43.51% | +26.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.53% | 52.93% | +37.60% |
Dividends
AXSM vs. DY - Dividend Comparison
Neither AXSM nor DY has paid dividends to shareholders.
Financials
AXSM vs. DY - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Dycom Industries, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. DY - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
DY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dycom Industries, Inc. reported a gross profit of 275.08M and revenue of 1.96B. Therefore, the gross margin over that period was 14.0%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
DY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dycom Industries, Inc. reported an operating income of 143.75M and revenue of 1.96B, resulting in an operating margin of 7.3%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
DY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dycom Industries, Inc. reported a net income of 91.29M and revenue of 1.96B, resulting in a net margin of 4.7%.
Frequently Asked Questions
AXSM and DY have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DY has higher volatility (26.09%) compared to AXSM (9.24%). In terms of maximum drawdown, AXSM dropped -86.65% vs DY's -93.54%.
AXSM currently has the higher Sharpe Ratio (3.37 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AXSM and DY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer